Monthly Archives: December 2018


FDA approves focused ultrasound to treat symptom of Parkinson’s

December 21, 2018 — Insightec announced that the U.S. Food and Drug Administration (FDA) has approved an expansion of the indication of Exablate Neuro to include the treatment of patients with tremor-dominant Parkinson’s disease (PD).

The Exablate Neuro is a focused ultrasound device for performing incisionless thalamotomy guided by magnetic resonance imaging (MRI). This expansion adds medication-refractory tremor from PD to the current Exablate Neuro indication for incisionless, focused ultrasound thalamotomy for medication-refractory essential tremor. Read more https://www.itnonline.com/content/fda-approves-exablate-neuro-tremor-dominant-parkinsons-treatment


Saturday December 14, 2019 – Holiday Get Together

Please join us at our Holiday Party to be held in the Terrace Room at Beverwyck on Saturday December 14 from 1:00 pm to 4:00pm.
Holiday appetizers will be served and we will have music and a number of fun activities in which everyone can take part.

We will be having a “ secret Santa “ gift exchange. If you would like to participate, please bring a gift valued around $10.

Cost will be $15 per person to be paid at the door.

Reservations closed. Room at capacity.

Questions? email to Ian Wing: iwing5033@gmail.com 518-794-0237. 
We look forward to seeing you there!



Speech and Swallowing in Parkinson’s Disease

In addition to the classic motor symptoms of Parkinson’s (tremor, slowness, stiffness, walking and/or balance problems), a person may develop changes in speech and/or swallowing. Although these problems can occur at any time in the course of Parkinson’s, they are more common as disease progresses.

Speech and swallowing therapy exercises, combined with Parkinson’s medication adjustment and, if necessary, dietary and/or behavioral modifications are the mainstays of management. Read more at https://www.michaeljfox.org/understanding-parkinsons/living-with-pd/topic.php?speech-swallowing

LSVT LOUD LSVT LOUD is an effective speech treatment for people with Parkinson’s disease (PD) and other neurological conditions.  Named for Mrs. Lee Silverman (Lee Silverman Voice Treatment), a woman living with PD, it was developed by Dr. Lorraine Ramig and has been scientifically studied for over 25 years with support from the National Institute for Deafness and other Communication Disorders within the National Institutes of Health (NIH) and other funding organizations. LSVT LOUD trains people with PD to use their voice at a more normal loudness level while speaking at home, work, or in the community. Read more at https://www.lsvtglobal.com/LSVTLoud